Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Leases (2019 - 2026)

Aytu Biopharma has reported Leases over the past 7 years, most recently at $959000.0 for Q4 2025.

  • Quarterly Leases fell 18.59% to $959000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $959000.0 through Dec 2025, down 18.59% year-over-year, with the annual reading at $1.1 million for FY2025, 27.99% up from the prior year.
  • Leases was $959000.0 for Q4 2025 at Aytu Biopharma, down from $1.0 million in the prior quarter.
  • Over five years, Leases peaked at $3.8 million in Q4 2021 and troughed at $700000.0 in Q3 2023.
  • The 5-year median for Leases is $2.1 million (2023), against an average of $2.2 million.
  • Year-over-year, Leases soared 1138.41% in 2021 and then tumbled 76.48% in 2023.
  • A 5-year view of Leases shows it stood at $3.8 million in 2021, then crashed by 30.43% to $2.7 million in 2022, then fell by 20.26% to $2.1 million in 2023, then crashed by 44.77% to $1.2 million in 2024, then dropped by 18.59% to $959000.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Leases are $959000.0 (Q4 2025), $1.0 million (Q3 2025), and $1.1 million (Q2 2025).